Dicyclohexano-18-crown-6, 97%, 250mg

6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, 95.0%, 100mg

(6-(Methoxycarbonyl)-1H-indol-2-yl)boronic acid, 95.0%, 100mg

3'-Chloro-5'-fluoroacetophenone>98.0%(GC)1g

1-(4-(2-Methoxyphenyl)piperazin-1-yl)-2-phenylethanone, 97%, 250mg

1-(Benzo[d]thiazol-5-yl)ethanone, 95.0%, 250mg

Plan PLPH S40x/0.65 phase contrast objective

1-(4-fluoro-3-nitrophenyl)-1H-pyrrole-2,5-dione, 1g

Paroxetine, 97%, 1g

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide, 99%, 5mg

4-bromo-7-methylpyrazolo[1,5-a]pyridine, 97.0%, 250mg

4-Phenyl-3-butyn-2-one>97.0%(GC)1g

Sodium bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate, 95.0%, 500g